ArticleEuropean heart journal. Case reports2026
Conduction system pacing using a rotatable connector enabling continuous pacing during lumenless lead deployment: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Conduction system pacing (CSP) is an alternative to right ventricular pacing, providing more physiological ventricular activation. Current guidelines recommend CSP for patients with an expected ventricular pacing burden >20% and mildly reduced left ventricular ejection fraction. However, consistent conduction capture is not always achieved, with success rates of around 80% in the MELOS trial. Lumenless leads (LL) are widely used for CSP, but sustained, real-time pacing and impedance monitoring could enhance procedural control and decrease procedure time. The integration of a tool to overcome this limitation was highlighted as a future development in the 2025 EHRA CSP consensus. We report the first case using this approach. Case summary: An 80-year-old man with paroxysmal complete atrioventricular block and mildly reduced ejection fraction underwent pacemaker implantation. CSP was selected as the pacing strategy according to current recommendations. A Medtronic® 3830 LL was delivered via a C315His sheath, connected to a Micropace® Onestim-CRM stimulator through the new rotator connector 5944RL. This configuration allowed simultaneous septal penetration and continuous pacing for real-time monitoring of current of injury and continuous impedance analysis. CSP success criteria were achieved-left ventricular activation time 62 ms, broad R' in V1, ventricular pacing thresholds for CSP 1.3 V @ 0.4 ms, fluoroscopy time 4:19 min, and shorter overall procedure (skin to skin, 50 min). Conclusion: To our knowledge, this case represents the first reported use of a rotatable connector for CSP lumenless lead deployment, demonstrating the feasibility of continuous pacing with LLs for CSP. Further experience is needed to confirm long-term performance and clinical impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.